Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical ...
The Offering was conducted on a firm commitment basis. AC Sunshine Securities LLC acted as the underwriter for the Offering ...
Global diagnostic company, Anbio Biotechnology (NNNN) priced its initial public offering of 1.6M shares at $5.00 per share.
The plaintiff is represented by Robbins Geller, which has extensive experience in prosecuting investor class actions including actions involving financial fraud. You can view a copy of the complaint ...
Seasoned biotechnology CEO brings 25 years of strategic, operational and commercial expertiseFOSTER CITY, Calif., Feb. 20, ...
Antimicrobial resistance (AMR) is a critical global health challenge, requiring early and accurate detection of resistance ...
Find out about what's behind the increase of securities class action lawsuits in the biotech industry and how to prevent them ...
Asian News International on MSN1d
Amity University Madhya Pradesh honours academic excellence at convocation for class of 2024Amity University Madhya Pradesh hosted its Convocation Ceremony for its class of 2024 in a grand and dignified atmosphere, on ...
The gross proceeds from the offering are expected to be $2,715,000, prior to offering expenses payable by the Company. The Company intends to use the net proceeds received from the private placement ...
Cornerstone Research recently issued its 2024 Year in Review report examining recent trends in securities class action filings. For the second year ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
Accelerating Uganda’s Leap into the New Economy Kampala, Uganda | THE INDEPENDENT | In a strategic move to accelerate Uganda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback